The Impact of Tocilizumab for Cytokine Release Syndrome on Bloodstream Infection Incidence After Haploidentical HCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantation
Leukemia and Lymphoma 2022 Jul 18;[EPub Ahead of Print], E De Togni, F Wan, M Slade, K Plach, R AbboudFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.